Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Braz. J. Pharm. Sci. (Online) ; 58: e20975, 2022. tab, graf
Article Dans Anglais | LILACS | ID: biblio-1420435

Résumé

Abstract Within recent past, coronavirus has shaken the whole world. The world faced a new pandemic of novel coronavirus 2019 (SARS-CoV-2/ COVID-19).It has socioeconomically impacted world population a lot in terms of education, economy as well as physical and mental health. This novel coronavirus is notorious enough that put human health at a great risk. Currently, researchers all over the world aretrying hard to develop a new drug/vaccine for its treatment. In past decades, the world population has faced various viral infectious illness outbreaks. Influenza A, Ebola, Zika, SARS and MERS viruses had whacked public health and economy. Medical science technology achieved the landmark in developing coronavirus (SARS-CoV-2) vaccines that are approved currently for emergency use. Some of the recently approved vaccines are developed by Pfizer and Moderna, Johnson and Johnson, Gam-COVID-vac (Sputnik V), Bharat Biotech (covaxin) andOxford-AstraZeneca vaccines (covishield) (Badenet al., 2021). Here, a short review is drafted focusingon infection, immune system, pathogenesis, phylogenesis, mode of transmission and impact of coronavirus on health and economy and recent developments in treating COVID-19


Sujets)
Coronavirus du syndrome respiratoire du Moyen-Orient/pathogénicité , COVID-19/anatomopathologie , Personnel de recherche/classification , Préparations pharmaceutiques/analyse , Coronavirus/pathogénicité , Syndrome respiratoire aigu sévère/diagnostic , Pandémies/classification , SARS-CoV-2/pathogénicité , Système immunitaire/malformations
SÉLECTION CITATIONS
Détails de la recherche